Financial Snapshot

Revenue
$37.89M
TTM
Gross Margin
64.84%
TTM
Net Earnings
-$54.90M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
417.68%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$66.93M
Q4 2024
Cash
Q4 2024
P/E
-7.248
Nov 29, 2024 EST
Free Cash Flow
-$35.47M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $59.35M $70.14M $138.6M $104.8M $69.06M $68.46M $60.59M $50.02M $48.84M $41.80M $35.31M $31.92M $88.30M $123.9M $107.1M $82.90M $50.50M $25.30M $12.10M $11.80M
YoY Change -15.39% -49.39% 32.3% 51.69% 0.87% 12.98% 21.13% 2.43% 16.82% 18.4% 10.6% -63.85% -28.71% 15.65% 29.2% 64.16% 99.6% 109.09% 2.54% 140.82%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $59.35M $70.14M $138.6M $104.8M $69.06M $68.46M $60.59M $50.02M $48.84M $41.80M $35.31M $31.92M $88.30M $123.9M $107.1M $82.90M $50.50M $25.30M $12.10M $11.80M
Cost Of Revenue $16.29M $12.81M $38.03M $22.21M $13.74M $15.63M $12.62M $14.33M $9.753M $6.586M $9.726M $14.55M $30.65M $41.78M $27.98M $16.70M $13.20M $8.300M $1.800M $2.200M
Gross Profit $43.06M $57.33M $100.6M $82.55M $55.31M $52.83M $47.97M $35.70M $39.08M $35.22M $25.58M $17.37M $57.65M $82.08M $79.12M $66.20M $37.30M $17.00M $10.30M $9.600M
Gross Profit Margin 72.55% 81.74% 72.56% 78.8% 80.1% 77.17% 79.17% 71.36% 80.03% 84.25% 72.45% 54.41% 65.29% 66.27% 73.87% 79.86% 73.86% 67.19% 85.12% 81.36%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Selling, General & Admin $55.15M $53.25M $52.17M $49.32M $35.05M $31.50M $29.29M $29.01M $25.42M $22.32M $21.94M $26.91M $31.38M $36.94M $33.84M $29.90M $35.70M $19.70M $11.90M $7.900M
YoY Change 3.56% 2.07% 5.78% 40.73% 11.26% 7.55% 0.98% 14.12% 13.91% 1.72% -18.47% -14.25% -15.06% 9.16% 13.18% -16.25% 81.22% 65.55% 50.63% 51.92%
% of Gross Profit 128.08% 92.88% 51.88% 59.75% 63.36% 59.63% 61.06% 81.26% 65.04% 63.36% 85.76% 154.93% 54.43% 45.01% 42.77% 45.17% 95.71% 115.88% 115.53% 82.29%
Research & Development $46.26M $58.89M $80.10M $55.92M $44.19M $33.87M $29.98M $29.66M $22.23M $20.67M $22.76M $31.61M $56.79M $61.05M $52.41M $54.70M $45.60M $35.60M $17.30M $12.80M
YoY Change -21.44% -26.48% 43.24% 26.56% 30.44% 12.99% 1.08% 33.42% 7.53% -9.15% -28.0% -44.34% -6.98% 16.49% -4.2% 19.96% 28.09% 105.78% 35.16% -0.78%
% of Gross Profit 107.45% 102.71% 79.66% 67.74% 79.88% 64.12% 62.49% 83.09% 56.87% 58.7% 88.95% 181.98% 98.5% 74.37% 66.23% 82.63% 122.25% 209.41% 167.96% 133.33%
Depreciation & Amortization $4.946M $5.518M $5.402M $3.113M $1.950M $1.570M $1.147M $1.042M $1.734M $5.410M $6.680M $10.31M $12.42M $11.48M $8.310M $6.130M $4.560M $2.880M $2.380M $2.450M
YoY Change -10.37% 2.15% 73.53% 59.64% 24.2% 36.88% 10.08% -39.91% -67.95% -19.01% -35.21% -16.99% 8.19% 38.15% 35.56% 34.43% 58.33% 21.01% -2.86%
% of Gross Profit 11.49% 9.62% 5.37% 3.77% 3.53% 2.97% 2.39% 2.92% 4.44% 15.36% 26.11% 59.36% 21.54% 13.99% 10.5% 9.26% 12.23% 16.94% 23.11% 25.52%
Operating Expenses $101.4M $112.1M $132.3M $105.2M $79.23M $65.38M $71.89M $72.99M $57.40M $42.99M $54.42M $73.07M $118.8M $139.8M $114.2M $84.60M $81.30M $55.40M $29.10M $20.80M
YoY Change -9.56% -15.22% 25.68% 32.82% 21.2% -9.06% -1.51% 27.17% 33.53% -21.0% -25.52% -38.5% -15.0% 22.36% 35.02% 4.06% 46.75% 90.38% 39.9% 14.92%
Operating Profit -$58.52M -$68.07M -$34.88M -$22.70M -$23.92M -$12.55M -$11.30M -$22.97M -$8.564M -$7.770M -$19.11M -$41.15M -$30.51M -$15.91M -$7.124M -$18.40M -$44.00M -$38.40M -$18.80M -$11.20M
YoY Change -14.03% 95.15% 53.68% -5.11% 90.61% 11.1% -50.83% 168.22% 10.22% -59.34% -53.55% 34.85% 91.82% 123.29% -61.28% -58.18% 14.58% 104.26% 67.86% -15.15%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Interest Expense $4.172M $1.441M $459.0K $400.0K $1.300M $700.0K $100.0K $100.0K $0.00 $0.00 $13.00K $0.00 $0.00 $529.0K -$1.200M -$900.0K $500.0K $200.0K $200.0K
YoY Change 189.52% 213.94% 14.75% -69.23% 85.71% 600.0% 0.0% -100.0% -100.0% -144.08% 33.33% -280.0% 150.0% 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$10.39M -$12.27M $124.0K $1.148M -$156.0K -$656.0K -$291.0K $92.00K $94.00K $168.0K $234.0K $304.0K $326.0K $675.0K $1.199M -$700.0K $100.0K -$1.500M -$200.0K -$400.0K
YoY Change -15.33% -9998.39% -89.2% -835.9% -76.22% 125.43% -416.3% -2.13% -44.05% -28.21% -23.03% -6.75% -51.7% -43.7% -271.29% -800.0% -106.67% 650.0% -50.0% 300.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Pretax Income -$65.24M -$76.17M -$33.32M -$21.09M -$23.67M -$11.92M -$10.65M -$22.99M -$8.174M -$7.641M -$20.98M -$41.70M -$30.59M -$16.31M -$8.157M -$20.20M -$44.80M -$39.40M -$18.80M -$11.30M
YoY Change -14.35% 128.63% 57.97% -10.9% 98.62% 11.87% -53.67% 181.31% 6.98% -63.58% -49.68% 36.32% 87.55% 99.94% -59.62% -54.91% 13.71% 109.57% 66.37% -13.74%
Income Tax $34.00K $69.00K $276.0K $189.0K $339.0K $17.00K -$37.00K $81.00K -$40.00K -$338.0K -$256.0K -$87.00K $270.0K $241.0K $384.0K $100.0K $300.0K -$400.0K -$100.0K $200.0K
% Of Pretax Income
Net Earnings -$65.28M -$76.24M -$33.59M -$21.28M -$24.01M -$11.94M -$10.88M -$23.00M -$8.558M -$7.581M -$19.07M -$41.30M -$30.86M -$16.55M -$8.541M -$20.30M -$45.10M -$39.00M -$18.70M -$11.60M
YoY Change -14.38% 126.96% 57.86% -11.37% 101.17% 9.72% -52.7% 168.71% 12.89% -60.25% -53.83% 33.85% 86.45% 93.77% -57.93% -54.99% 15.64% 108.56% 61.21% -11.45%
Net Earnings / Revenue -109.99% -108.69% -24.24% -20.31% -34.77% -17.43% -17.95% -45.97% -17.52% -18.13% -54.01% -129.39% -34.95% -13.36% -7.97% -24.49% -89.31% -154.15% -154.55% -98.31%
Basic Earnings Per Share -$0.89 -$1.12 -$0.51 -$0.33 -$0.40 -$0.21
Diluted Earnings Per Share -$0.89 -$1.12 -$0.51 -$0.33 -$0.40 -$0.21 -$208.8K -$497.8K -$211.8K -$192.9K -$500.0K -$1.081M -$839.7K -$465.0K -$345.5K -$7.808M -$18.79M -$22.94M -$17.00M -$7.733M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Cash & Short-Term Investments $65.12M $114.0M $116.8M $150.1M $90.50M $53.00M $31.20M $19.20M $23.30M $26.50M $25.10M $45.50M $53.50M $72.40M $55.60M $37.10M $84.10M $32.20M
YoY Change -42.87% -2.41% -22.19% 65.86% 70.75% 69.87% 62.5% -17.6% -12.08% 5.58% -44.84% -14.95% -26.1% 30.22% 49.87% -55.89% 161.18%
Cash & Equivalents $65.12M $114.0M $116.8M $149.1M $90.50M $53.00M $31.20M $19.20M $23.30M $26.50M $22.10M $32.00M $25.80M $72.40M $31.80M $21.90M $55.10M $32.20M
Short-Term Investments $0.00 $1.000M $0.00 $3.000M $13.50M $27.70M $0.00 $23.80M $15.20M $29.00M $0.00
Other Short-Term Assets $5.737M $6.008M $6.279M $4.000M $3.200M $1.100M $1.000M $1.200M $1.200M $1.300M $3.800M $5.400M $2.300M $1.600M $1.700M $2.100M $2.800M $700.0K
YoY Change -4.51% -4.32% 56.98% 25.0% 190.91% 10.0% -16.67% 0.0% -7.69% -65.79% -29.63% 134.78% 43.75% -5.88% -19.05% -25.0% 300.0%
Inventory $2.685M $2.029M $1.160M $1.000M $400.0K $600.0K $1.000M $800.0K $1.000M $1.400M $1.500M $1.300M $4.500M $2.800M $2.900M $3.000M $1.600M $700.0K
Prepaid Expenses
Receivables $19.93M $40.87M $37.65M $29.30M $20.20M $13.50M $11.80M $5.900M $7.300M $3.900M $5.400M $7.500M $18.90M $15.30M $7.200M $6.200M $6.400M $2.800M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $93.47M $162.9M $161.9M $184.4M $114.2M $68.20M $45.00M $27.20M $32.80M $33.00M $35.80M $59.80M $79.20M $92.20M $67.40M $48.30M $94.90M $36.30M
YoY Change -42.62% 0.62% -12.21% 61.47% 67.45% 51.56% 65.44% -17.07% -0.61% -7.82% -40.13% -24.49% -14.1% 36.8% 39.54% -49.1% 161.43%
Property, Plant & Equipment $28.62M $61.88M $65.46M $31.20M $30.40M $4.800M $2.800M $2.200M $3.100M $4.000M $8.400M $16.70M $24.20M $21.50M $21.60M $16.00M $11.10M $4.500M
YoY Change -53.74% -5.47% 109.8% 2.63% 533.33% 71.43% 27.27% -29.03% -22.5% -52.38% -49.7% -30.99% 12.56% -0.46% 35.0% 44.14% 146.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.700M $20.51M $14.00M $1.500M $0.00 $600.0K $700.0K $1.100M $1.500M $700.0K $800.0K $3.600M $10.30M $1.700M
YoY Change -52.71% 46.48% 833.47% -100.0% -14.29% -36.36% -26.67% 114.29% -12.5% -77.78% -65.05% 505.88%
Other Assets $2.308M $1.871M $1.795M $1.400M $1.200M $2.500M $1.900M $1.900M $1.100M $1.000M $1.000M $3.700M $2.500M $2.600M $5.900M $1.600M $1.700M $1.300M
YoY Change 23.36% 4.23% 28.21% 16.67% -52.0% 31.58% 0.0% 72.73% 10.0% 0.0% -72.97% 48.0% -3.85% -55.93% 268.75% -5.88% 30.77%
Total Long-Term Assets $43.10M $87.50M $84.50M $37.20M $34.90M $11.10M $8.600M $8.400M $11.80M $15.10M $23.00M $40.20M $56.70M $49.10M $31.60M $22.60M $18.60M $10.10M
YoY Change -50.75% 3.56% 127.14% 6.59% 214.41% 29.07% 2.38% -28.81% -21.85% -34.35% -42.79% -29.1% 15.48% 55.38% 39.82% 21.51% 84.16%
Total Assets $136.6M $250.4M $246.4M $221.6M $149.1M $79.30M $53.60M $35.60M $44.60M $48.10M $58.80M $100.0M $135.9M $141.3M $99.00M $70.90M $113.5M $46.40M
YoY Change
Accounts Payable $5.947M $3.246M $2.995M $3.000M $2.600M $3.100M $3.500M $4.200M $3.400M $4.700M $4.000M $3.700M $10.40M $9.200M $11.30M $12.60M $12.00M $3.100M
YoY Change 83.21% 8.38% -0.17% 15.38% -16.13% -11.43% -16.67% 23.53% -27.66% 17.5% 8.11% -64.42% 13.04% -18.58% -10.32% 5.0% 287.1%
Accrued Expenses $19.76M $32.09M $27.79M $20.20M $12.70M $9.400M $8.400M $5.800M $5.300M $5.600M $5.200M $10.40M $14.10M $13.70M $16.90M $12.60M $10.70M $4.100M
YoY Change -38.42% 15.48% 37.57% 59.06% 35.11% 11.9% 44.83% 9.43% -5.36% 7.69% -50.0% -26.24% 2.92% -18.93% 34.13% 17.76% 160.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.000M $1.400M $1.500M $600.0K
YoY Change -100.0% 42.86% -6.67% 150.0%
Long-Term Debt Due $0.00 $100.0K $5.400M $5.200M $4.500M $1.600M
YoY Change -100.0% 3.85% 15.56% 181.25%
Total Short-Term Liabilities $35.83M $49.07M $33.37M $25.00M $15.40M $18.10M $25.00M $12.40M $14.80M $13.70M $11.20M $16.30M $28.30M $27.50M $51.00M $42.40M $34.20M $13.60M
YoY Change -26.98% 47.03% 33.48% 62.34% -14.92% -27.6% 101.61% -16.22% 8.03% 22.32% -31.29% -42.4% 2.91% -46.08% 20.28% 23.98% 151.47%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $300.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.600M $8.500M $12.90M $2.500M
YoY Change -100.0% -66.67% -100.0% -69.41% -34.11% 416.0%
Other Long-Term Liabilities $14.12M $56.53M $48.62M $26.60M $28.20M $4.800M $3.800M $4.200M $6.900M $8.100M $6.200M $5.200M $4.900M $6.500M $10.70M $16.40M $21.20M $5.500M
YoY Change -75.03% 16.27% 82.79% -5.67% 487.5% 26.32% -9.52% -39.13% -14.81% 30.65% 19.23% 6.12% -24.62% -39.25% -34.76% -22.64% 285.45%
Total Long-Term Liabilities $14.12M $56.53M $48.62M $26.60M $28.20M $4.900M $4.100M $4.200M $6.900M $8.100M $6.200M $5.200M $4.900M $6.500M $13.30M $24.90M $34.10M $8.000M
YoY Change -75.03% 16.27% 82.79% -5.67% 475.51% 19.51% -2.38% -39.13% -14.81% 30.65% 19.23% 6.12% -24.62% -51.13% -46.59% -26.98% 326.25%
Total Liabilities $49.95M $105.6M $81.99M $51.50M $43.60M $23.00M $29.10M $16.50M $21.80M $21.80M $17.40M $21.50M $33.20M $33.90M $64.20M $67.30M $68.30M $21.60M
YoY Change -52.7% 28.79% 59.21% 18.12% 89.57% -20.96% 76.36% -24.31% 0.0% 25.29% -19.07% -35.24% -2.06% -47.2% -4.61% -1.46% 216.2%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $397.94 Million

About CODEXIS, INC.

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. The company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. The company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Industry: Industrial Organic Chemicals Peers: Absci Corp Akoya Biosciences, Inc. Nautilus Biotechnology, Inc. Inotiv, Inc. Bionano Genomics, Inc. SomaLogic, Inc. Quantum-Si Inc Quanterix Corp Seer, Inc. THERMO FISHER SCIENTIFIC INC.